← FDA Drug Approvals (Drugs@FDA)
HYLENEX RECOMBINANT
BLA · Biologics License Application · Sponsor: HALOZYME THERAP · Approved 2005-12-02
Drug application
- FDA Application #
BLA021859- Application type
- Biologics License Application
- Brand name
- HYLENEX RECOMBINANT
- Generic name
- HYALURONIDASE
- Active ingredients
- HYALURONIDASE RECOMBINANT HUMAN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- HALOZYME THERAP
- Manufacturer
- Antares Pharma, Inc.
- First approval
- 2005-12-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown